BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 21549035)

  • 1. Quantitative determination of latrunculins A and B in the Red Sea sponge Negombata magnifica by high performance liquid chromatography.
    Khalifa S; Ahmed S; Mesbah M; Youssef D; Hamann M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):47-51. PubMed ID: 16431167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
    Tan KL; Ankathil R; Gan SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3583-91. PubMed ID: 22000961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection.
    Yokoyama Y; Nozawa E; Morita M; Ishikawa E; Mori T; Sakurai M; Kikuchi T; Matsuki E; Yamazaki R; Kataoka K; Jibiki A; Kawazoe H; Suzuki S; Nakamura T
    J Clin Lab Anal; 2022 Aug; 36(8):e24598. PubMed ID: 35819095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia.
    Fujioka Y; Sugiyama D; Matsumura I; Minami Y; Miura M; Atsuta Y; Ohtake S; Kiyoi H; Miyazaki Y; Nishikawa H; Takahashi N
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards point of care systems for the therapeutic drug monitoring of imatinib.
    Pearce CM; Resmini M
    Anal Bioanal Chem; 2020 Sep; 412(24):5925-5933. PubMed ID: 32166445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism.
    Zhou Y; Yamamura Y; Ogawa M; Tsuji R; Tsuchiya K; Kasahara J; Goto S
    Front Pharmacol; 2018; 9():1311. PubMed ID: 30505273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative method for the determination of bosutinib in human plasma using high-performance liquid chromatography and ultraviolet detection.
    Sumimoto T; Nakahara R; Sato Y; Itoh H
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.
    Rezende VM; Rivellis A; Novaes MM; de Alencar Fisher Chamone D; Bendit I
    Drug Des Devel Ther; 2013; 7():699-710. PubMed ID: 23946646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance.
    Rezende VM; Rivellis AJ; Gomes MM; Dörr FA; Novaes MM; Nardinelli L; Costa AL; Chamone DA; Bendit I
    Rev Bras Hematol Hemoter; 2013; 35(2):103-8. PubMed ID: 23741187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction.
    Shinohara Y; Takahashi N; Nishiwaki K; Hino M; Kashimura M; Wakita H; Hatano Y; Hirasawa A; Nakagawa Y; Itoh K; Masuoka H; Aotsuka N; Matsuura Y; Takahara S; Sano K; Kuroki J; Hata T; Nakamae H; Mugitani A; Nakane T; Miyazaki Y; Niioka T; Miura M; Sawada K
    Haematologica; 2013 Sep; 98(9):1407-13. PubMed ID: 23716542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
    Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
    J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of an HPLC method for determination of imatinib mesylate in rat serum and its application in a pharmacokinetic study.
    Bende G; Kollipara S; Movva S; Moorthy G; Saha R
    J Chromatogr Sci; 2010; 48(5):334-41. PubMed ID: 20515524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography.
    Miura M; Uno T; Tateishi T; Suzuki T
    J Pharm Biomed Anal; 2007 Jan; 43(2):741-5. PubMed ID: 16934428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
    Miura M; Takahashi N; Sawada K
    J Chromatogr Sci; 2011 May; 49(5):412-5. PubMed ID: 21549035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma.
    Miura M; Takahashi N; Sawada K
    Biomed Chromatogr; 2010 Jul; 24(7):789-93. PubMed ID: 19904720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
    Kralj E; Trontelj J; Pajič T; Kristl A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.